Reggy, A A <br/><br/>
Using 3'-azido-2',3'-dideoxythymidine (AZT) to prevent perinatal human immunodeficiency virus transmission and risk of transplacental carcinogenesis.  [electronic resource] 

 -  Journal of the National Cancer Institute  Nov 1997 
 - 1566-7 p.  digital 
<br/><br/> Publication Type: Comment; Editorial 
<br/><br/><label>ISSN: </label>0027-8874 
<br/><br/><label>Standard No.: </label>10.1093/jnci/89.21.1566  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anti-HIV Agents--administration & dosage<br/>Carcinogens--administration & dosage<br/>Female<br/>HIV Infections--prevention & control<br/>Humans<br/>Infant, Newborn<br/>Infectious Disease Transmission, Vertical--prevention & control<br/>Mice<br/>National Institutes of Health (U.S.)<br/>Placenta<br/>Pregnancy<br/>Pregnancy Complications, Infectious<br/>Risk<br/>United States<br/>Zidovudine--administration & dosage